Ameritas Investment Partners’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,165
| Closed | -$6K | – | 3327 |
|
|
2022
Q1 | $6K | Hold |
2,165
| – | – | ﹤0.01% | 2953 |
|
|
2021
Q4 | $10K | Hold |
2,165
| – | – | ﹤0.01% | 2916 |
|
|
2021
Q3 | $18K | Hold |
2,165
| – | – | ﹤0.01% | 2759 |
|
|
2021
Q2 | $36K | Hold |
2,165
| – | – | ﹤0.01% | 2411 |
|
|
2021
Q1 | $48K | Hold |
2,165
| – | – | ﹤0.01% | 2114 |
|
|
2020
Q4 | $67K | Hold |
2,165
| – | – | ﹤0.01% | 1816 |
|
|
2020
Q3 | $44K | Buy |
2,165
+1,191
| +122% | +$24.2K | ﹤0.01% | 1919 |
|
|
2020
Q2 | $15K | Hold |
974
| – | – | ﹤0.01% | 2522 |
|
|
2020
Q1 | $8K | Hold |
974
| – | – | ﹤0.01% | 2660 |
|
|
2019
Q4 | $14K | Hold |
974
| – | – | ﹤0.01% | 2605 |
|
|
2019
Q3 | $15K | Buy |
974
+817
| +520% | +$12.6K | ﹤0.01% | 2558 |
|
|
2019
Q2 | $2K | Buy |
+157
| New | +$2K | ﹤0.01% | 3030 |
|